VFWPX
Price
$124.15
Change
-$2.23 (-1.76%)
Updated
Sep 6 closing price
VGTSX
Price
$19.63
Change
-$0.35 (-1.75%)
Updated
Sep 6 closing price
Ad is loading...

VFWPX vs VGTSX

Header iconVFWPX vs VGTSX Comparison
Open Charts VFWPX vs VGTSXBanner chart's image
Vanguard FTSE All-Wld ex-US Idx Ins Plus
Price$124.15
Change-$2.23 (-1.76%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$19.63
Change-$0.35 (-1.75%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VFWPX vs VGTSX Comparison Chart
Loading...
VS
VFWPX vs. VGTSX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VFWPX is a StrongSell and VGTSX is a StrongSell.

FUNDAMENTALS
Fundamentals
VGTSX has more cash in the bank: 453B vs. VFWPX (57.6B). VFWPX (3.36) and VGTSX (3.20) have matching dividends . VFWPX was incepted earlier than VGTSX: VFWPX (14 years) vs VGTSX (28 years). VFWPX (4.00) and VGTSX (4.00) have comparable annual turnover. VGTSX has a lower initial minimum investment than VFWPX: VGTSX (0) vs VFWPX (100000000). VFWPX (14.15) and VGTSX (13.70) have marching annual gain over last year. VFWPX (25.64) and VGTSX (25.36) have equivalent 5 years return.
VFWPXVGTSXVFWPX / VGTSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years28 years-
Gain YTD8.1227.621107%
Front LoadN/AN/A-
Min. Initial Investment1000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets57.6B453B13%
Annual Yield % from dividends3.363.20105%
Returns for 1 year14.1513.70103%
Returns for 3 years-3.78-4.6681%
Returns for 5 years25.6425.36101%
Returns for 10 years26.5726.26101%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCTI0.740.03
+4.53%
Healthcare Triangle
NFGC2.590.02
+0.78%
New Found Gold Corp
IFS25.030.04
+0.16%
Intercorp Financial Services
NBIX121.12-1.42
-1.16%
Neurocrine Biosciences
SGMO0.75-0.05
-5.88%
Sangamo Therapeutics